BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 19622581)

  • 1. A spontaneous acinar cell carcinoma model for monitoring progression of pancreatic lesions and response to treatment through noninvasive bioluminescence imaging.
    Zhang N; Lyons S; Lim E; Lassota P
    Clin Cancer Res; 2009 Aug; 15(15):4915-24. PubMed ID: 19622581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noninvasive imaging of spontaneous retinoblastoma pathway-dependent tumors in mice.
    Vooijs M; Jonkers J; Lyons S; Berns A
    Cancer Res; 2002 Mar; 62(6):1862-7. PubMed ID: 11912166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurogenin 3-directed cre deletion of Tsc1 gene causes pancreatic acinar carcinoma.
    Ding L; Han L; Li Y; Zhao J; He P; Zhang W
    Neoplasia; 2014 Nov; 16(11):909-17. PubMed ID: 25425965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A bioluminescent mouse model of pancreatic {beta}-cell carcinogenesis.
    Zumsteg A; Strittmatter K; Klewe-Nebenius D; Antoniadis H; Christofori G
    Carcinogenesis; 2010 Aug; 31(8):1465-74. PubMed ID: 20530553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninvasive visualization of retinoblastoma growth and metastasis via bioluminescence imaging.
    Ji X; Cheng L; Wei F; Li H; Wang M; Tian Y; Chen X; Wang Y; Wolf F; Li C; Huang Q
    Invest Ophthalmol Vis Sci; 2009 Dec; 50(12):5544-51. PubMed ID: 19608529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue plasminogen activator in murine exocrine pancreas cancer: selective expression in ductal tumors and contribution to cancer progression.
    Aguilar S; Corominas JM; Malats N; Pereira JA; Dufresne M; Real FX; Navarro P
    Am J Pathol; 2004 Oct; 165(4):1129-39. PubMed ID: 15466380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A bioluminescence imaging based in vivo model for preclinical testing of novel cellular immunotherapy strategies to improve the graft-versus-myeloma effect.
    Rozemuller H; van der Spek E; Bogers-Boer LH; Zwart MC; Verweij V; Emmelot M; Groen RW; Spaapen R; Bloem AC; Lokhorst HM; Mutis T; Martens AC
    Haematologica; 2008 Jul; 93(7):1049-57. PubMed ID: 18492693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreas-specific activation of mTOR and loss of p53 induce tumors reminiscent of acinar cell carcinoma.
    Kong B; Cheng T; Qian C; Wu W; Steiger K; Cao J; Schlitter AM; Regel I; Raulefs S; Friess H; Erkan M; Esposito I; Kleeff J; Michalski CW
    Mol Cancer; 2015 Dec; 14():212. PubMed ID: 26683340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The generation of a conditional reporter that enables bioluminescence imaging of Cre/loxP-dependent tumorigenesis in mice.
    Lyons SK; Meuwissen R; Krimpenfort P; Berns A
    Cancer Res; 2003 Nov; 63(21):7042-6. PubMed ID: 14612492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term survival in a patient with acinar cell carcinoma of pancreas. A case report and review of literature.
    Antoine M; Khitrik-Palchuk M; Saif MW
    JOP; 2007 Nov; 8(6):783-9. PubMed ID: 17993731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acinous-cell carcinoma of a metastatic pancreas treated by chemotherapy].
    Corbinais S; Egreteau J; Garin L; Derrien G; Boucher E; Raoul JL
    Gastroenterol Clin Biol; 2002 Dec; 26(12):1180-1. PubMed ID: 12520210
    [No Abstract]   [Full Text] [Related]  

  • 12. Pancreatic-type acinar cell carcinoma of the stomach beneath a focus of pancreatic metaplasia of the gastric mucosa.
    Ambrosini-Spaltro A; Potì O; De Palma M; Filotico M
    Hum Pathol; 2009 May; 40(5):746-9. PubMed ID: 19144387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of claudin-4 molecule in canine exocrine pancreatic acinar cell carcinomas.
    Jakab CS; Rusvai M; Demeter Z; Gálfi P; Szabó Z; Kulka J
    Histol Histopathol; 2011 Sep; 26(9):1121-6. PubMed ID: 21751143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acinar cell carcinoma of the pancreas: is the absence of neuroendocrine component related to a more malignant behavior?
    Machado MC; Machado MA; Perini MV; Herman P; Jukemura J; Leite KR; Bacchella T
    Hepatogastroenterology; 2008; 55(82-83):708-10. PubMed ID: 18613439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel method of monitoring response to islet transplantation: bioluminescent imaging of an NF-kB transgenic mouse model.
    Roth DJ; Jansen ED; Powers AC; Wang TG
    Transplantation; 2006 Apr; 81(8):1185-90. PubMed ID: 16641606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noninvasive monitoring of changes in pancreatic beta-cell mass by bioluminescent imaging in MIP-luc transgenic mice.
    Park SY; Bell GI
    Horm Metab Res; 2009 Jan; 41(1):1-4. PubMed ID: 18949679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation and characterization of islet cell tumor in pTet-on/pTRE-SV40Tag double-transgenic mice model.
    Shen Q; Sun Q; Wei X; Dong J; Zhang R; Wu P; Jin Y; Feng J; Li H; Hu Y
    J Biosci Bioeng; 2007 Jul; 104(1):14-21. PubMed ID: 17697978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acinar cell carcinoma of the pancreas metastatic to the ovary: a report of 4 cases.
    Vakiani E; Young RH; Carcangiu ML; Klimstra DS
    Am J Surg Pathol; 2008 Oct; 32(10):1540-5. PubMed ID: 18724247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Chronic" metastatic pancreatic acinar cell carcinoma.
    Cananzi FC; Jayanth A; Lorenzi B; Belgaumkar A; Mochlinski K; Sharma A; Mudan S; Cunningham D
    Pancreatology; 2013; 13(5):549-52. PubMed ID: 24075523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New insights into alcoholic pancreatitis and pancreatic cancer.
    Apte M; Pirola R; Wilson J
    J Gastroenterol Hepatol; 2009 Oct; 24 Suppl 3():S51-6. PubMed ID: 19799699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.